GenScript?USA Inc. (Piscataway, NJ), and Santa Cruz Biotechnology Inc. (Santa Cruz, CA?...">

澳门太阳游戏城app官网入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.

Immunogastroenterology.. 2012-09;  1(1):27-33
Satish Ramalingam, Prabhu Ramamoorthy, Dharmalingam Subramaniam, Shrikant Anant. Department of Molecular and Integrative Physiology, Kansas University Cancer Center, University of Kansas Medical Center, Kansas, USA
Products/Services Used Details Operation

摘要

Background & Aims: Colon cancer is the third leading cause of cancer death in both men and women in the United States. Every year, 160000 cases of colorectal cancer are diagnosed, and 57000 patients die. CUGBP, Elav-like family member 2 (CELF2) is an RNA binding protein that modulates various posttranscriptional events including RNA splicing, shuttling, editing, stability and translation. Previous studies have demonstrated that CELF2 expression is low in colon cancer cells. Furthermore, ectopic overexpression of CELF2 induces cells to undergo death by mitotic catastrophe. Based on the above observations, we hypothesized that CELF2 expression might be reduced during neoplastic transformation of colon cells. Met... More

关键词

intestine; tumors; cell death